lactoferrin and Schistosomiasis-haematobia

lactoferrin has been researched along with Schistosomiasis-haematobia* in 2 studies

Other Studies

2 other study(ies) available for lactoferrin and Schistosomiasis-haematobia

ArticleYear
Schistosoma haematobium: identification of new estrogenic molecules with estradiol antagonistic activity and ability to inactivate estrogen receptor in mammalian cells.
    Experimental parasitology, 2010, Volume: 126, Issue:4

    We have previously identified the expression of an estradiol (E2)-related molecule by Schistosoma haematobium total antigen (Sh). We now show that this molecule has an antagonistic effect of estradiol in vitro. Our results are consistent with the existence of an estrogenic molecule that antagonizes the activity of estradiol. We found evidence for this molecule as we identified and characterized by mass spectrometry new estrogenic molecules previously unknown, present in schistosome worm extracts and sera of Schistosoma-infected individuals. We also show that Sh is able to interact in vitro with estrogen receptor (ER), explaining how host endocrine system can favor the establishment of schistosomes. These findings highlight the exploitation of the host endocrine system by schistosomes and represent an additional regulatory component of schistosome development that defines a novel paradigm enabling host-parasite interactions. The identification of these molecules opens new ways for the development of alternative drugs to treat schistosomiasis.

    Topics: Animals; Antigens, Helminth; Cell Line; CHO Cells; Cricetinae; Cricetulus; Down-Regulation; Estradiol; Estrogen Antagonists; Estrogens; Female; Humans; Lactoferrin; Mesocricetus; Receptors, Estrogen; Schistosoma haematobium; Schistosomiasis haematobia

2010
The utility of lactoferrin in differentiating parasitic from bacterial infections.
    Journal of the Egyptian Society of Parasitology, 2005, Volume: 35, Issue:3 Suppl

    Lactoferrin is an iron binding glycoprotein found in the 2ry granules of PMN. In order to determine the usefulness of such marker for neutrophilic activity in differentiating cases suffering from amoebic and bacillary dysentery, Schistosoma and bacterial UTI infections, we examined stool and urine specimens using anti-lactoferrin antibodies (lactoferrin latex agglutination test: LFLA), compared with different standard gold techniques. Our results demonstrated that cases with either shigllosis or UTI revealed a high lactoferrin titer which was positively correllated with the number of PMN. In addition cases with Entamoeba histolytica or S. haematobium were characterized by relatively lower inflammatory process as expressed by mild lactoferrin titer which was also correlated with the PMN count. In addition, the findings of the present work indicated that LFLA was sensitive and specific when used alone and its sensitivity was augmented after coupling with other simple indirect methods of diagnosis. In conclusion, results described the reliability of using LFLA as a simple, rapid, sensitive method in differentiating, certain parasitic from bacterial diseases.

    Topics: Animals; Diagnosis, Differential; Dysentery, Amebic; Dysentery, Bacillary; Entamoeba histolytica; Feces; Humans; Lactoferrin; Schistosoma haematobium; Schistosomiasis haematobia; Shigella

2005